All In Biotech

Free tool

FAERS Monitor: Altreno

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209353 or its brand name (Altreno, Tretinoin). Reports on generic versions are filed under their own applications.

Reports

6,579

Serious

4,119

63% of reports

Hospitalization

1,417

Death reported

851

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use877
  • drug ineffective731
  • product use in unapproved indication493
  • pain490
  • vomiting450
  • paraesthesia373
  • abdominal pain upper368
  • rash362
  • nausea351
  • diarrhoea347
  • maternal exposure during pregnancy338
  • headache335
  • taste disorder332
  • drug intolerance327
  • gastrooesophageal reflux disease327

Reports by year received

View as table
YearReports
200437
200531
200624
200739
2008114
200972
201078
201189
2012153
2013100
2014147
2015223
2016342
2017343
2018461
2019356
2020381
2021434
2022514
2023572
2024684
2025819
2026566

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,580 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
taste disorderSignal33253.247.816,682
gastrooesophageal reflux diseaseSignal32713.011.73,621
maternal exposure during pregnancySignal33812.211.03,454
drug intoleranceSignal32710.99.82,919
paraesthesiaSignal3737.66.92,141
product use in unapproved indicationSignal4936.45.92,249
abdominal pain upperSignal3685.75.21,441
off label useSignal8773.23.01,384
vomitingSignal4503.12.8636
rashSignal3622.72.4380
painSignal4902.62.3474
drug ineffective7311.81.7262
diarrhoea3471.71.6107
headache3351.71.5101
nausea3511.41.344

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.